Joel Credle

Joel Credle is a scientific co-founder and director of research and development at Infinity Bio, Inc., where work focuses on characterizing individual antibody repertoires. In addition, Credle co-founded Portal Bioscience LLC, a precision pathology company that develops advanced RNA analysis solutions, including the innovative Lock'n'Roll™ technology. Previously, Credle held positions as a laboratory manager and postdoctoral fellow at Johns Hopkins Medicine, specializing in spatial biology and antibody profiling, and conducted significant research at Georgetown University focusing on the unfolded protein response and Parkinson's disease. Credle earned a Ph.D. in biochemistry and molecular biology from Georgetown University and completed postdoctoral training at The Johns Hopkins University School of Medicine.